Cargando…

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant

The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant of concern (VOC) has destabilized global efforts to control the impact of coronavirus disease 2019 (COVID-19). Recent data have suggested that B.1.1.529 can readily infect people with natura...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yu, Cai, Curtis, Grifoni, Alba, Müller, Thomas R., Niessl, Julia, Olofsson, Anna, Humbert, Marion, Hansson, Lotta, Österborg, Anders, Bergman, Peter, Chen, Puran, Olsson, Annika, Sandberg, Johan K., Weiskopf, Daniela, Price, David A., Ljunggren, Hans-Gustaf, Karlsson, Annika C., Sette, Alessandro, Aleman, Soo, Buggert, Marcus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2022
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938268/ https://www.ncbi.nlm.nih.gov/pubmed/35042228 http://dx.doi.org/10.1038/s41591-022-01700-x

Ejemplares similares

SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants
por: Lindahl, Hannes, et al.
Publicado: (2023)

T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial
por: Blixt, Lisa, et al.
Publicado: (2022)

Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant
por: Lindahl, Hannes, et al.
Publicado: (2022)

Functional SARS-CoV-2 cross-reactive CD4(+) T cells established in early childhood decline with age
por: Humbert, Marion, et al.
Publicado: (2023)

Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination
por: Blixt, Lisa, et al.
Publicado: (2022)

Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination
por: Gao, Yu, et al.
Publicado: (2022)

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID
por: Chen, Puran, et al.
Publicado: (2023)

Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia
por: Andersson, Maria, et al.
Publicado: (2023)

From Alpha to omicron: The response of T cells
por: Grifoni, Alba, et al.
Publicado: (2022)

SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
por: Tarke, Alison, et al.
Publicado: (2022)

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
por: Bergman, Peter, et al.
Publicado: (2021)

T cell immunity to SARS-CoV-2
por: Niessl, Julia, et al.
Publicado: (2021)

Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox
por: Adamo, Sarah, et al.
Publicado: (2023)

P609: EFFECT OF LONG-TERM ZANUBRUTINIB TREATMENT ON T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A STUDY CONDUCTED IN PARALLEL WITH THE BGB-3111-304 AND 305 TRIALS.
por: Andersson, Maria, et al.
Publicado: (2023)

Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals
por: Healy, Katie, et al.
Publicado: (2022)

T cell responses to SARS-CoV-2 spike cross-recognize Omicron
por: Keeton, Roanne, et al.
Publicado: (2022)

MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine
por: Boulouis, Caroline, et al.
Publicado: (2022)

Elevated CD21(low) B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency
por: Bergman, Peter, et al.
Publicado: (2022)

Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIV
por: Ghorbani, Mahin, et al.
Publicado: (2023)

NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals
por: Cuapio, Angelica, et al.
Publicado: (2022)

Human T Cell Response to Dengue Virus Infection
por: Tian, Yuan, et al.
Publicado: (2019)

Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize Omicron
por: Keeton, Roanne, et al.
Publicado: (2022)

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern
por: Schultz, Bárbara M., et al.
Publicado: (2022)

Perturbed CD8(+) T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals
por: Tauriainen, Johanna, et al.
Publicado: (2017)

SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation
por: Sandberg, John Tyler, et al.
Publicado: (2021)

Do reduced numbers of plasmacytoid dendritic cells contribute to the aggressive clinical course of COVID‐19 in chronic lymphocytic leukaemia?
por: Smith, Carl Inge Edvard, et al.
Publicado: (2022)

Omicron Booster in Ancestral Strain Vaccinated Mice Augments Protective Immunities Against Both Delta and Omicron Variants
por: Jia, Liqiu, et al.
Publicado: (2022)

The effects of person-centered or other supportive interventions in older women with osteoporotic vertebral compression fractures—a systematic review of the literature
por: Svensson, H. K., et al.
Publicado: (2017)

Increased Stability of SARS-CoV-2 Omicron Variant over Ancestral Strain
por: Chin, Alex Wing Hong, et al.
Publicado: (2022)

PB1924: INCIDENCE OF CARDIOVASCULAR AND BLEEDING EVENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS (CLL) TREATED WITH IBRUTINIB – A RETROSPECTIVE ANALYSIS ON CONSECUTIVE PATIENTS FROM A WELL-DEFINED REGION.
por: Andersson, Maria, et al.
Publicado: (2023)

Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection
por: Frederiksen, Juliet, et al.
Publicado: (2015)

Identifying Candidate Targets of Immune Responses in Zika Virus Based on Homology to Epitopes in Other Flavivirus Species
por: Xu, Xiaojun, et al.
Publicado: (2016)

SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
por: Grifoni, Alba, et al.
Publicado: (2021)

SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
por: Grifoni, Alba, et al.
Publicado: (2022)

Incidence and root causes of cancellations for elective orthopaedic procedures: a single center experience of 17,625 consecutive cases
por: Caesar, Ulla, et al.
Publicado: (2014)

A painful, never ending story: older women’s experiences of living with an osteoporotic vertebral compression fracture
por: Svensson, H. K., et al.
Publicado: (2015)

Incidence of pulmonary embolism in COVID-19 infection in the ED: ancestral, Delta, Omicron variants and vaccines
por: Law, Nicole, et al.
Publicado: (2022)

Novaferon Effectively Inhibits Ancestral SARS-CoV-2 and Omicron Variant in Vitro, 2022
por: Ye, Fei, et al.
Publicado: (2022)

Incidence and severity of pulmonary embolism in COVID-19 infection: Ancestral, Alpha, Delta, and Omicron variants
por: Wada, Noriaki, et al.
Publicado: (2023)

Unique transcriptional and protein-expression signature in human lung tissue-resident NK cells
por: Marquardt, Nicole, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ear4ub04i74oit39bchkpjfkae